Eruptive keratoacanthomas secondary to nivolumab immunotherapy.
Int J Dermatol
; 57(3): e28-e29, 2018 03.
Article
in En
| MEDLINE
| ID: mdl-29318617
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Drug Eruptions
/
Antineoplastic Agents, Immunological
/
Nivolumab
/
Keratoacanthoma
Type of study:
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Female
/
Humans
Language:
En
Journal:
Int J Dermatol
Year:
2018
Document type:
Article
Affiliation country:
Estados Unidos